Effects of COVID-19 in maternal and perinatal morbidity and mortality among obstetrics patients in tertiary care center
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20230518Keywords:
COVID-19, Mortality, SARS-CoV-2, Maternal and perinatal morbidityAbstract
Background: By the end of 2019, WHO had identified COVID-19 disease as a public health emergency. Research has focused on the impact of SARS-CoV-2 infection during pregnancy, including symptoms, disease severity, risk of vertical transmission, and perinatal and neonatal prognosis.
Methods: This was a cross sectional prospective observational study, conducted at Gynae and Obstetric Department, in Bangabandhu Sheikh Mujib Medical University, between July 2020 to August 2021. 75 pregnant women who tested positive for COVID-19 were included in this study.
Results: Most of the patients 29(38.7%) were aged 25-29 years. Majority 96% (72) of the cases were asymptomatic, symptomatic cases with cough were 4% (3). On the basis of our data, 94.7% (71) of the cases were Antenatal, while Postnatal and Abortion were 4% (3) and 1.3% (1) respectively. Complications such as fetal distress 25.3% (19), scar tenderness 17.3% (13), pre-eclampsia 12% (9), post-dated pregnancy 9.3% (7), previous 2LSCS with pain abdomen 2.7% (2), oligohydramnios 2.7% (2), malpresentation (transverse lie) 1.3% (1). All pregnant postpartum women were administered antibiotics and enoxaparin. 60% (45) were given HCQ, 40% (30) were given Antiviral drugs, 40% (30) were given Steroids. Injection methyl-prednisolone and tablet hydroxychloroquine 400 mg 12 hourly loading dose on day 1 followed by 200 mg 12 hourly for next 4 days and improvement in symptoms were noted. 16% (12) were managed conservatively and only 1.3% (1) were ICU admissions.
Conclusions: In this study, we found that the majority of patients had moderate or no symptoms and discharged with satisfactory outcome.
References
Novel coronavirus situation report-2. Available at: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200122-sitrep-2-2019-ncov. Accessed on 14 January 2021.
Investigating the impact of COVID-19 on pregnancy. Available at: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/special-populations/pregnancy-data-on-covid-19/what-cdcis-doing.html. Accessed on 14 January 2021.
Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-June 7, 2020. Morbid Mortal Week Rep. 2020;69(25):769.
Badr DA, Mattern J, Carlin A, Cordier AG, Maillart E, El Hachem L, et al. Are clinical outcomes worse for pregnant women ate” 20 weeks’ gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching. Am J Obstet Gynecol. 2020;223(5):764-8.
Chavan N, Mahapatra S, Venkateswaran S, Ponkshe,J, Nayak A. Impact of COVID-19 infection on maternal near miss cases in tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2021;10(7):2671.
COVID-19: investigation and initial clinical management of possible cases 2020. Available at: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initialinvestigation-of-possible cases/investigation-and-initial-clinical-management of-possible-cases-of-wuhannovel-coronavirus-wncov-infection. Accessed on 14 January 2021.
Aditya R, Fitria Y. Hubungan Tingkat Kecemasan dan Pengetahuan Ibu Hamil Tentang Antenatal Care Saat Pandemi Covid-19. Available at: http://www.um. ac.id/index.php/psi. Accessed on 14 January 2021.
Ri K. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Available at: https://covid19.go.id/p/protokol/pedoman-pencegahan-dan-pengendalian-coronavirus-disease-covid-19-revisi-ke-5. Accessed on 14 January 2021.
Docherty AB, Harrison EM, Green CA. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterization Protocol: prospective observational cohort study. BMJ. 2020; 369:1985.
Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020;222(5):415-26.
Walker KF, O’Donoghue K, Grace N. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG. 2020;127(11): 1324-36.
COVID-19 testing. Available at: https://www.icmr. gov.in. Accessed on 20 November 2022.
Muhidin S, Behboodi Moghadam Z, Vizheh M. Analysis of maternal coronavirus infections and neonates born to mothers with 2019-nCoV; a systematic review. Arch Acad Emerg Med. 2020;8: e49.
Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020;369:2107.
Ghia T, di Pasquoa E, Mekinianb A, Calzac L, Fruscaa T. Sars-CoV-2 in pregnancy: Why is it better than expected? Eur J Obstet Gynecol Reprod Biol. 2020; 252:476-8.
Yan J, Guo J, Fan C, Juan J, Yu X, Li J, et al. Coronavirus disease 2019 (COVID-19) in pregnant women: a report based on 116 cases. Am J Obstetr Gynecol. 2020;223(1):111e1-14.
Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16:153-68.
Lokken EM, Walker CL, Delaney S, Kachikis A, Kretzer NM, Erickson A. Clinical characteristics of 46 pregnant women with a SARS-CoV-2 infection in Washington state. Am J Obstetr Gynecol. 2020; 223(6):911e1-14.
